论文部分内容阅读
抗帕金森病药物在该病患者常见的讷吃的作用不一致,作者曾试验出氯硝安定对帕金森病讷吃有效,本文用双盲试验调查氯硝安定对治疗该病讷吃的作用。研究12例少动讷吃帕金森病患者,2例系脑炎后,10例系特发性,平均年龄72岁,平均病期11年,研究时仍用常规抗帕金森病药,在基线、安慰剂、氯硝安定0.5mg和1mg4种情况下评价,最后6例因常见困倦副作用另加氯硝安定0.25mg,患者接受每种治疗1周,中间停止1周。随机将患者分入一治疗顺序,晚间给药或安慰剂,在一天相同时间和相同运动
Parkinson’s disease anti-Parkinson’s disease drugs in patients with common role in the eating is not consistent, the authors have tested clonazepam Parkinson’s disease to eat effectively, this paper double-blind trial of clonazepam on the treatment of the disease to eat the role. Twelve cases of Parkinson’s disease were studied in 12 children with adolescents. After two cases of encephalitis, 10 cases were idiopathic, with an average age of 72 years and an average of 11 years. Conventional antiparkinsonian drugs were also used in the study. , Placebo, clonazepam 0.5mg and 1mg 4 cases of evaluation, the last 6 cases of common drowsiness side effects plus clonazepam 0.25mg, patients receiving each treatment for 1 week, the middle stop for 1 week. Patients were randomly assigned to a treatment sequence, evening administration or placebo, at the same time of the day and the same exercise